The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy

Anthony S. Basile, Kuniaki Saito, Hanaan Al-Mardini, Christopher O. Record, Robin D. Hughes, Phil Harrison, Roger Williams, Yong Li, Melvyn P. Heyes

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background/Aims: Quinolinic acid is an endogenous neuroexcitant derived from tryptophan. Brain quinolinic acid concentrations are reportedly elevated in chronic liver failure. The aim of this study was to determine if brain quinolinic acid levels correlate with the severity of hepatic encephalopathy. Methods: Postmortem samples of selected brain regions and plasma samples taken at several stages of encephalopathy were obtained from patients with acute and chronic liver failure. Quinolinic acid levels were measured by mass spectroscopy using [18O]quinolinic acid. Results: Plasma quinolinic acid levels were significantly increased by stage I encephalopathy in patients with acute liver failure and by stages II and III in patients with chronic liver failure. Brain quinolinic acid levels were elevated only in patients with acute liver failure and were uniformly distributed at concentrations below those observed in plasma. Conclusions: The uniform distribution of quinolinic acid at subplasma concentrations in the brains of patients with acute liver failure suggests that it is synthesized peripherally and enters the brain across a permeabilized blood-brain barrier. Whereas the elevation of brain quinolinic acid levels in patients who died of acute but not chronic liver failure suggests that the involvement of quinolinic acid in the pathogenesis of hepatic encephalopathy is minimal, it could predispose these patients to seizures.

Original languageEnglish
Pages (from-to)818-823
Number of pages6
JournalGastroenterology
Volume108
Issue number3
DOIs
Publication statusPublished - 01-01-1995
Externally publishedYes

Fingerprint

Quinolinic Acid
Hepatic Encephalopathy
Brain
End Stage Liver Disease
Acute Liver Failure
Brain Diseases
Blood-Brain Barrier
Tryptophan
Mass Spectrometry
Seizures

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Basile, A. S., Saito, K., Al-Mardini, H., Record, C. O., Hughes, R. D., Harrison, P., ... Heyes, M. P. (1995). The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. Gastroenterology, 108(3), 818-823. https://doi.org/10.1016/0016-5085(95)90456-5
Basile, Anthony S. ; Saito, Kuniaki ; Al-Mardini, Hanaan ; Record, Christopher O. ; Hughes, Robin D. ; Harrison, Phil ; Williams, Roger ; Li, Yong ; Heyes, Melvyn P. / The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. In: Gastroenterology. 1995 ; Vol. 108, No. 3. pp. 818-823.
@article{a605e91dc2da4d7c97c8cdfcd82daa44,
title = "The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy",
abstract = "Background/Aims: Quinolinic acid is an endogenous neuroexcitant derived from tryptophan. Brain quinolinic acid concentrations are reportedly elevated in chronic liver failure. The aim of this study was to determine if brain quinolinic acid levels correlate with the severity of hepatic encephalopathy. Methods: Postmortem samples of selected brain regions and plasma samples taken at several stages of encephalopathy were obtained from patients with acute and chronic liver failure. Quinolinic acid levels were measured by mass spectroscopy using [18O]quinolinic acid. Results: Plasma quinolinic acid levels were significantly increased by stage I encephalopathy in patients with acute liver failure and by stages II and III in patients with chronic liver failure. Brain quinolinic acid levels were elevated only in patients with acute liver failure and were uniformly distributed at concentrations below those observed in plasma. Conclusions: The uniform distribution of quinolinic acid at subplasma concentrations in the brains of patients with acute liver failure suggests that it is synthesized peripherally and enters the brain across a permeabilized blood-brain barrier. Whereas the elevation of brain quinolinic acid levels in patients who died of acute but not chronic liver failure suggests that the involvement of quinolinic acid in the pathogenesis of hepatic encephalopathy is minimal, it could predispose these patients to seizures.",
author = "Basile, {Anthony S.} and Kuniaki Saito and Hanaan Al-Mardini and Record, {Christopher O.} and Hughes, {Robin D.} and Phil Harrison and Roger Williams and Yong Li and Heyes, {Melvyn P.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0016-5085(95)90456-5",
language = "English",
volume = "108",
pages = "818--823",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

Basile, AS, Saito, K, Al-Mardini, H, Record, CO, Hughes, RD, Harrison, P, Williams, R, Li, Y & Heyes, MP 1995, 'The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy', Gastroenterology, vol. 108, no. 3, pp. 818-823. https://doi.org/10.1016/0016-5085(95)90456-5

The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. / Basile, Anthony S.; Saito, Kuniaki; Al-Mardini, Hanaan; Record, Christopher O.; Hughes, Robin D.; Harrison, Phil; Williams, Roger; Li, Yong; Heyes, Melvyn P.

In: Gastroenterology, Vol. 108, No. 3, 01.01.1995, p. 818-823.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy

AU - Basile, Anthony S.

AU - Saito, Kuniaki

AU - Al-Mardini, Hanaan

AU - Record, Christopher O.

AU - Hughes, Robin D.

AU - Harrison, Phil

AU - Williams, Roger

AU - Li, Yong

AU - Heyes, Melvyn P.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Background/Aims: Quinolinic acid is an endogenous neuroexcitant derived from tryptophan. Brain quinolinic acid concentrations are reportedly elevated in chronic liver failure. The aim of this study was to determine if brain quinolinic acid levels correlate with the severity of hepatic encephalopathy. Methods: Postmortem samples of selected brain regions and plasma samples taken at several stages of encephalopathy were obtained from patients with acute and chronic liver failure. Quinolinic acid levels were measured by mass spectroscopy using [18O]quinolinic acid. Results: Plasma quinolinic acid levels were significantly increased by stage I encephalopathy in patients with acute liver failure and by stages II and III in patients with chronic liver failure. Brain quinolinic acid levels were elevated only in patients with acute liver failure and were uniformly distributed at concentrations below those observed in plasma. Conclusions: The uniform distribution of quinolinic acid at subplasma concentrations in the brains of patients with acute liver failure suggests that it is synthesized peripherally and enters the brain across a permeabilized blood-brain barrier. Whereas the elevation of brain quinolinic acid levels in patients who died of acute but not chronic liver failure suggests that the involvement of quinolinic acid in the pathogenesis of hepatic encephalopathy is minimal, it could predispose these patients to seizures.

AB - Background/Aims: Quinolinic acid is an endogenous neuroexcitant derived from tryptophan. Brain quinolinic acid concentrations are reportedly elevated in chronic liver failure. The aim of this study was to determine if brain quinolinic acid levels correlate with the severity of hepatic encephalopathy. Methods: Postmortem samples of selected brain regions and plasma samples taken at several stages of encephalopathy were obtained from patients with acute and chronic liver failure. Quinolinic acid levels were measured by mass spectroscopy using [18O]quinolinic acid. Results: Plasma quinolinic acid levels were significantly increased by stage I encephalopathy in patients with acute liver failure and by stages II and III in patients with chronic liver failure. Brain quinolinic acid levels were elevated only in patients with acute liver failure and were uniformly distributed at concentrations below those observed in plasma. Conclusions: The uniform distribution of quinolinic acid at subplasma concentrations in the brains of patients with acute liver failure suggests that it is synthesized peripherally and enters the brain across a permeabilized blood-brain barrier. Whereas the elevation of brain quinolinic acid levels in patients who died of acute but not chronic liver failure suggests that the involvement of quinolinic acid in the pathogenesis of hepatic encephalopathy is minimal, it could predispose these patients to seizures.

UR - http://www.scopus.com/inward/record.url?scp=0028968783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028968783&partnerID=8YFLogxK

U2 - 10.1016/0016-5085(95)90456-5

DO - 10.1016/0016-5085(95)90456-5

M3 - Article

VL - 108

SP - 818

EP - 823

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -